104
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 92-96 | Received 18 Aug 2022, Accepted 20 Jan 2023, Published online: 20 Feb 2023
 

Abstract

Objective

To evaluate the acceptance rate of post-placental intrauterine device (PPIUD) placement during the SARS-CoV-2 (COVID-19) pandemic and to to assess factors associated with PPIUD acceptance.

Methods

A cross-sectional study was conducted between August 2020 and August 2021. PPIUDs were offered to women scheduled for caesarean delivery or admitted in labour at the Women’s Hospital of the University of Campinas. The study compared women according to whether they accepted or did not accept the IUD placement. The factors associated with PPIUD acceptance were analysed through bivariate and multiple logistic regression analyses.

Results

We enrolled 299 women (15.9% of the deliveries that occurred during study period), aged 26.8 ± 6.5 years; 41.8% were White, almost one third were primiparous, and 155/299 (51.8%) had a vaginal delivery. The PPIUD acceptance rate was 65.6%. The principal reason for refusal was the desire for another contraceptive (41.8%). Women with the highest likelihood of accepting a PPIUD were younger (<30 years old has 1.7 more likely or 74% greater), those without a partner (3.4 times more likely) and those after vaginal delivery (1.7 times more likely or 69% greater)

Conclusion

The COVID-19 does not affected the PPIUD placement. PPIUD is a viable alternative during crisis in which women has difficult to access health services. Younger women, those without a partner and after vaginal delivery were more likely to accept a PPIUD during the COVID-19 pandemic.

SHORT CONDENSATION

Post-placental IUDs are an alternative during periods of crisis like the COVID-19 pandemic. Younger women, those without a partner and after vaginal delivery were more likely to accept a PPIUD during the COVID-19 pandemic.

摘要

目的:评价SARS-CoV-2 (COVID-19)大流行期间胎盘娩出后放置宫内节育器(PPIUD)的接受率, 并评估与PPIUD接受度相关的因素。

方法:在2020年8月至2021年8月期间进行横断面研究。向在坎皮纳斯大学妇产医院计划剖宫产或自然分娩的女性提供宫内节育器。该研究根据女性是否接受IUD进行了比较。通过双变量和多元logistic回归分析与PPIUD接受度相关的因素。

结果:本研究招募了299名女性(15.9%在研究期间分娩), 年龄26.8±6.5岁;41.8%为白人, 近三分之一为初产妇, 155/299(51.8%)为经阴道分娩。PPIUD的接受率为65.6%。拒绝的主要原因是想要另一种避孕方法(41.8%)。PPIUD接受可能性最高的是年轻女性(<30岁者可能性高1.7倍或高出74%), 没有伴侣的女性(高出3.4倍)和经阴道分娩后的女性(高出1.7倍或高出69%)。

结论:COVID-19不影响PPIUD的放置。在女性难以获得保健服务的危机期间, 宫内节育器是一种可行的避孕替代方案。在COVID-19大流行期间, 年轻女性、没有伴侣的女性和经阴道分娩后的女性更有可能接受PPIUD。

简短总结

在COVID-19大流行等危机时期, 胎盘娩出后放置宫内节育器是一种替代选择。在COVID-19大流行期间, 年轻女性、没有伴侣的女性和经阴道分娩后的女性更有可能接受PPIUD。

Disclosure statement

Luis Bahamondes received an honorarium from Bayer Pharma as speaker. The other authors declare no conflict of interest.

Additional information

Funding

This study received partial financial support from the Fundação de Apoio à Pesquisa do Estado de São Paulo (FAPESP) award No. 2020/14899-9 and from the Brazilian National Research Council (CNPq) grant No. 305179/2019-5.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 416.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.